Copenhagen University Hospital

Older adults who remain active recover faster from hospitalization, surgery, and acute illnesses than their sedentary peers.

One of my favorite studies comes from Aging Cell, led by Abel Plaza-Florido, with collaborators across UC Irvine, Copenhagen University Hospital, and Lund University, published in 2025.

The researchers studied people aged 100 to 104, and they asked a simple question, does movement still matter that late in life? The answer was a resounding yes.

After just a brief bout of physical activity, centenarians showed a measurable drop in inflammatory proteins and the activation of protective immune and stress response pathways that were largely silent at rest.

The research, published in The Lancet Regional Health, is an observational study.

The results were interesting enough that researchers, um, in Copenhagen University Hospital are urging doctors to consider statin therapy when diagnosing type 2 patients, saying that statins seem to be underused in patients with type 2.

Semaglutide may provide an unexpected benefit for people with asthma.

New researchers found that semaglutide use was associated with a reduction in asthma attacks of nearly 40%.

Now, a nationwide study from Denmark may begin to provide answers to that question.

Researchers from the Danish Multiple Sclerosis Registry at Copenhagen University Hospital examined data from 3,316 adults living with MS who began treatment between 2012 and 2022.

2,722 of these patients began their treatment on moderate efficacy therapies with the option to escalate, and 594 patients initiated treatment using high efficacy therapies.

These patients were followed for between one and a half and just over 13 years.

So we're excited to have two guests with us today.

One I already mentioned, Professor Henning Bundgaard, who's the senior author of the POET trial and a clinical professor in the Department of Cardiology at the Heart Center at Copenhagen University Hospital in Denmark.

And our other guest is Sammy Aldilati, who Emily will introduce in a moment.

And Sammy has published studies looking at the uptake of oral antibiotics for endocarditis after the publication of the POET trial.

Welcome to this program titled The World Patient, integrating the lived experience of myasthenia gravis.

Joining me today are Malin Misso, who is a clinical nurse specialist, a senior researcher, and an associate professor at the Copenhagen University Hospital and the University of Copenhagen, Denmark.

And Zeynep Alani, who is a medical student and BSc graduate from the University of Glasgow School of Medicine, alongside being a generalized myasthenia gravis patient and a rare condition advocate from Glasgow, Scotland.

Welcome.